Enveric Biosciences Shares Surge Following Trump's Executive Order on Psychedelics
Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order
Benzinga
Image: Benzinga
Enveric Biosciences Inc (NASDAQ:ENVB) experienced a significant surge of over 92% in premarket trading after President Donald Trump signed an executive order to expedite the approval of psychedelic treatments for serious mental illnesses. This regulatory shift has sparked a broader rally in the psychedelic biotech sector.
- 01Enveric's shares rose over 92% following Trump's executive order.
- 02The order directs federal agencies to accelerate the approval of psychedelic treatments.
- 03A commitment of $50 million for ibogaine research signifies federal support.
- 04Despite the surge, Enveric's long-term stock trend remains cautious.
- 05Key resistance and support levels for ENVB are $4.50 and $3.50, respectively.
Advertisement
In-Article Ad
Enveric Biosciences Inc (NASDAQ:ENVB) saw its stock price soar by over 92% in premarket trading on Monday after President Donald Trump signed an executive order to expedite the approval process for psychedelic-based treatments aimed at serious mental illnesses such as PTSD and depression. The executive order not only instructs federal health agencies to speed up review timelines but also commits $50 million to support research on ibogaine, a Schedule I substance in the U.S. This marks a significant federal endorsement of psychedelic medicine, which has shown promising clinical results but faced regulatory hurdles. Despite the recent surge, Enveric's long-term stock trend remains cautious, with shares trading 47.2% below the 200-day simple moving average. Key resistance is identified at $4.50, while support is at $3.50.
Advertisement
In-Article Ad
The executive order could lead to faster access to psychedelic treatments for mental health conditions, benefiting patients in need of alternative therapies.
Advertisement
In-Article Ad
Reader Poll
Do you support the acceleration of psychedelic treatment approvals?
Connecting to poll...
Read the original article
Visit the source for the complete story.